IL-21 signaling is critical for the development of type I diabetes in the NOD mouse.
IL-21 is a pleiotropic type I cytokine that shares the common cytokine receptor gamma chain and plays important roles for normal Ig production, terminal B cell differentiation to plasma cells, and Th17 differentiation. IL-21 is elevated in several autoimmune diseases, and blocking its action has attenuated disease in MRL/lpr mice and in collagen-induced arthritis. The diabetes-associated Idd3 locus is at the Il2/Il21 locus, and elevated IL-21 was observed in the nonobese diabetic (NOD) mouse and suggested to contribute to diabetes by augmenting T cell homeostatic proliferation. To determine the role of IL-21 in diabetes, Il21r-knockout (KO) mice were backcrossed to NOD mice. These mice were devoid of lymphocytic infiltration into the pancreas, and only 1 of 20 animals had an elevated glucose compared with 60% of NOD mice on a wild-type (WT) background. Although TCR and Treg-related responses were normal, these mice had reduced Th17 cells and significantly higher levels of mRNAs encoding members of the Reg (regenerating) gene family whose transgenic expression protects against diabetes. Our studies establish a critical role for IL-21 in the development of type I diabetes in the NOD mouse, with obvious potential implications for type I diabetes in humans.
Spolski
Rosanne
R
Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Building 10, Room 7B05, Bethesda, MD 20892-1674, USA.
Kashyap
Mohit
M
Robinson
Constance
C
Yu
Zuxi
Z
Leonard
Warren J
WJ
D000818:Animals; D015415:Biomarkers; D049109:Cell Proliferation; D002478:Cells, Cultured; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D018450:Disease Progression; D007378:Interleukins / Q000276:immunology* / Q000378:metabolism; D018655:Lymphocyte Count; D051379:Mice; D016688:Mice, Inbred NOD; D018345:Mice, Knockout; D010179:Pancreas / Q000276:immunology / Q000378:metabolism; D053655:Receptors, Interleukin-21 / Q000172:deficiency / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D015398:Signal Transduction / Q000276:immunology*; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology; D015854:Up-Regulation; D000098546:Interleukin-21
D015415:Biomarkers; D007378:Interleukins; D053655:Receptors, Interleukin-21; D000098546:Interleukin-21
Immunity. 2002 Apr;16(4):559-69
11970879
J Immunol. 2007 Mar 15;178(6):3822-30
17339481
J Exp Med. 2008 Jan 21;205(1):207-18
18195074
Diabetes. 2002 Dec;51 Suppl 3:S478-83
12475793
Nat Immunol. 2007 Sep;8(9):967-74
17581537
Nat Genet. 2007 Mar;39(3):329-37
17277778
Science. 2002 Nov 22;298(5598):1630-4
12446913
Diabetes. 2008 Jan;57(1):113-23
17928397
Nature. 2005 May 26;435(7041):452-8
15917799
Diabetes. 2003 Feb;52(2):327-34
12540604
Gene. 1997 Feb 7;185(2):159-68
9055810
Diabetes. 2007 Jan;56(1):34-40
17192462
J Exp Med. 2005 Jan 3;201(1):139-48
15630141
Nature. 2007 Jul 26;448(7152):480-3
17581589
J Immunol. 2007 Mar 1;178(5):2827-34
17312126
Cell. 1993 Apr 9;73(1):147-57
8462096
Nature. 2000 Nov 2;408(6808):57-63
11081504
J Immunol. 2004 Nov 1;173(9):5361-71
15494482
Arthritis Rheum. 2007 Apr;56(4):1152-63
17393408
Immunity. 2000 Apr;12(4):431-40
10795741
Cell. 2004 Apr 16;117(2):265-77
15084263
Physiol Genomics. 2005 Apr 14;21(2):201-11
15671250
Diabetes. 2002 Feb;51(2):339-46
11812740
Nature. 2007 Jul 26;448(7152):484-487
17581588
Cell Mol Life Sci. 2005 Nov;62(22):2658-68
16261264
Eur J Immunol. 2006 Jan;36(1):216-23
16358360
Annu Rev Immunol. 2008;26:57-79
17953510
Annu Rev Immunol. 2005;23:447-85
15771578